TMJ Disorders Market 2023 Leading Players | AbbVie Inc, Bayer AG, Jubilant Cadista, Pfizer Inc, Sun Pharmaceutical

The Global TMJ Disorders Market is expected to grow at the CAGR of ~3.9% during the forecast period and is estimated to reach USD 1229.1 million by 2023.

TMJ (temporomandibular joint and muscle) ailment is a clinical circumstance which causes disorder and ache inside the jaw joint and the muscular tissues that manipulate jaw motion. The medical situation is recognized more regularly in girls than the guys. In keeping with the yank academy of orofacial pain, TMJ issues may also have more than one symptoms and reasons.

A number of the foremost signs of this sickness are aching facial pain, tenderness or pain in jaws, ache even as chewing and many others. TMJ problems can arise if the joint's cartilage is damaged by way of arthritis or by means of a blow or other impact or the disk erodes or moves out of its proper alignment.

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/4090 .

The major drivers will be the increasing prevalence of TMJ disorder, rising healthcare expenditures and growing awareness for the oral health. According to the National Institute of Dental and Craniofacial Research in 2014, the prevalence of temporomandibular joint and muscle disorder (TMJD) was in between 5% to 12%. Moreover, according to the Centers for Medicare & Medicaid Services in 2016, the U.S. healthcare expenditure was about USD 3.3 trillion, which accounted for 17.9% of the total GDP within the same year.

Global TMJ Disorders Market - Competitive Analysis

Pfizer Inc. is a U.S. based Biopharmaceutical Company and plays a significant role in the TMJ disorders market. The company’s total revenue was about USD 52,824 million in 2016. Moreover, it was estimate that the company spent 14.9% of its total revenue in research and development which made the company to improve its position in the global market and enhance its product portfolio.

In March 2017, ALLERGAN announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLLURE XC, for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21.

AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Jubilant Cadista (US), Pfizer Inc. (US), and Sun Pharmaceutical Industries Ltd. (India) are some of the prominent players at the forefront of competition in the global TMJ disorders market and are profiled in MRFR Analysis. Global TMJ Disorders Market - Regional Analysis.

Regional Analysis of the Global TMJ disorders Market

The Americas dominate the global TMJ disorders market. According to National Institute of Dental and Craniofacial Research, approximately 10 million people are suffering from this disorder in the US alone. North America region, especially US is the dominating country in this market due to various reasons such as advanced medical facilities, ongoing research and clinical trials related to TMJ disorder, and availability of skilled health professionals. In Latin American countries, awareness of this disorder is growing which is driving the market growth in this region.

Get Attractive Discount on this Report @ https://www.marketresearchfuture.com/check-discount/4090 .

Increasing cases of TMJ disorder is leading the market growth in European region. Availability of advanced diagnostic and therapeutic options are also playing important role in the growth of this market. Ongoing research by medical research laboratories and academic institutes are leading to new developments for effective cure of this disorder. Other factors such as highly skilled medical professionals, well aware patients, and extended insurance cover are driving the market growth.

…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.